期刊文献+

39例皮肤黑素瘤临床病理分析 被引量:3

Clinical and histopathological analysis of 39 cases of cutaneous melignant melanoma
下载PDF
导出
摘要 目的 探索皮肤黑素瘤的临床和组织病理特点。方法 回顾性分析(2008-2015)年昆明医科大学第一附属医院皮肤科确诊的39例皮肤恶性黑素瘤临床特点及组织病理学特点,并进行Clark(1969)分级。结果 39例皮肤恶性黑色素瘤中男性患者15例(38.5%),女性24例(61.5%);发病年龄在(17-84)岁之间,平均年龄(58.5±12.5)岁;发病部位肢端31例(79.5%),面部6例(15.3%),背部及左膝关节各1例(2.6%);出现溃疡者17例(43.6%),无溃疡者22例(56.4%);临床与病理诊断符合病例数31例,占统计病例79.5%;免疫组化染色结果示S-100(+)27例(69.23%),HMB-45(+)28例(71.79%),Melanin-A(27)例(69.23%),Ki-67(+)24例(61.54%)。结论 皮肤黑素瘤发病年龄以中老年为主,肢端部位好发,斑疹侵袭深度为II级及以下,斑块、结节及溃疡侵袭深度为III级及以上。 Objective To analysis the clinical and pathological characteristics of 39 cases of cutaneous melignant melanoma. Methods To analyze clinical and pathological characteristics of 39 patients with cutaneous malignant melanoma diagnosed at the Department of Dermatology, the First Affiliated Hospi- tal of Kunming Medical University from 2008 to 2015 retrospectively. Resulta Among the 39 cases of cutaneous malignant melanoma, male patients is 15 cases (38.5 % ) , females is 24 cases (61.5 % ) ; their age is between 17 and 84 years, the mean age is 58.5±12.5, there are 2 cases whose age were under the 20 (5.2%) , 3 cases between the ages of 20 and 40 (7.7%) , 13 cases are in 41-60 years of age ( 33.3 % ) , and 21 cases are over the age of 61 ( 53. 8% ) ; involvement parts of limb is 31 cases (79.5%) , 6 cases of patients with lesions on the face ( 15.3% ) , only 1 case is in the left knee and back sev- erally (2.6%), 17 cases with ulcer(43.6% ), no ulcer in 22 cases (56.4%). All patients, the clinical diagnosis accorded with pathology accounts for 31 patients (79.5%) ; immunohistochemical staining of S 100 (+) accounts for 27 (69.23%), HMB 45 (+) is 28 (71.79%), Melanin-A is 27 cases ( 69.23 % ) , Ki-67 ( + ) is 24 ( 61.54% ). Conclusion Clinical characteristics of CMM : the skin melanoma occured mainly in the elderly ; the lesions are more to be acral sites. Spotted invasion depth is II level and below; plaques, nodules and ulcers invasion depth is III and above.
出处 《皮肤病与性病》 2016年第5期317-319,共3页 Dermatology and Venereology
基金 云南省科技厅-昆明医科大学应用基础研究联合专项(2013FB138)
关键词 皮肤黑素瘤 组织病理学 临床特征 Cutaneous melignant melanoma Histopathology Clinical features
  • 相关文献

参考文献6

  • 1Dzwierzynski WW. Managing malignant melanoma [ J]. Plastic and Reconstructive Surgery,2013,132 (3) : 446-460.
  • 2郭智俊,黄美云,肖宁新.恶性黑色素瘤86例临床病理分析[J].医学研究杂志,2008,37(9):87-89. 被引量:7
  • 3Mooi W J. The dysplastic naevus [ J]. Journal of Clinical Patholo- gy, 1997,50(9) :711-715.
  • 4Botella L M, Tilman S E, Francisco S R, et al. Transcriptional. ac- tivation of endoglin and transforming growth factor-beta signaling components by cooperative interaction between Spl and KLF6 : their potential role in the response to vascular injury [ J ]. Collegium Antropologicum ,2002,32 ( 3 ) :315-319.
  • 5姜承易,余红.黑素瘤诊治进展[J].中国麻风皮肤病杂志,2015,31(10):596-599. 被引量:2
  • 6刘彤云,何黎.皮肤黑素瘤的诊断和治疗[J].皮肤病与性病,2015,37(3):145-147. 被引量:5

二级参考文献37

  • 1周际昌.实用肿瘤内科学.北京:人民卫生出版社,2010.
  • 2Ben -Izhak O, Stark P, Levy R . Epithelial markers in malignant melanoma. Astudyof prinmary lesions and their metastases. Am J Dematopathol, 1994,16 ( 3 ) : 241 - 246
  • 3Achilles E, Schroder S. Positive cytokeratin results in malignant melanoma. Pitfall in differential immunohistological diagnosis of occult neoplasms. Pathology, 1994, 15 (4) : 235 - 241
  • 4Lee R J, Gibbs JF ,Proulx GM,et al. Nodal Basin Recurrencu Following Lymph Node Dissection For Melanoma: Implications For Adjuvant Radiotherapy. Int. J. Radiation Oncology. Phys, 2000, 46 ( 2 ) :467 - 474
  • 5Barth A, Wanek LA, Morton DL. Prognostic factors in 1521 melanoma Patients with distant metastases . J Am Coil Surg, 1995,181 (2) : 193 -201
  • 6Balch CM, Urist MM, Karakousis CP, et al. Efficacy of 2 - cm surgical margins for intermediate - thickness melanomas( 1 to 4 mm). resuits of a muhiinstitutional randomized surgical trial. Ann Surg 1993, 218(2) :262 -267
  • 7Kanemaru H, Fukushima S, Yamashita J, et al. The circulating microRNA-221 level in patients with malignant melanoma as a new tumor marker. J Dermatol Sci,2011,61(3) :187-193.
  • 8Bastiaannet E, Uyl-de Groot CA, Brouwers AH, et al. Cost-ef- fectiveness of adding FDG-PET or CT to the diagnostic work-up of patients with stage III melanoma. Ann Surg, 2012,255 (4): 771-776.
  • 9Morton DL, Thompson JF, Cochran A J, et al. Final trial report of sentinel-node biopsy versus nodal observation in melanoma. N Engl J Med,2014,370(7) :599-609.
  • 10Cui C, Mao L, Chi Z, et al. A phase II, randomized, double- blind, placebo-controlled muhicenter trial of Endostar in pa- tients with metastatic melanoma. Mol Ther, 2013,21 (7) :1456- 1463.

共引文献11

同被引文献22

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部